AA Medical Products Ltd successfully conducted a hybrid scientific symposium titled “Rethinking Inflammation: From Symptoms to Sustained Control” at Inya Ballroom, Melia Hotel, Yangon, with strong participation from the medical community.
The program was graced by Mr. Zaw Moe Khine, Chairman of Pacific-AA Group, and Dr. Saw Nay Nwe, Vice Chairwoman of Pacific-AA Group, who delivered the corporate appreciation message.
The scientific session was chaired by Professor Chit Soe, Consultant Physician and Rheumatologist, who also delivered an insightful presentation on managing inadequate response in Rheumatoid Arthritis. Professor Khaing Khaing Zaw, Consultant Dermatologist, shared valuable clinical perspectives on Alopecia Areata and Atopic Dermatitis, highlighting the importance of timely recognition, proper escalation, and improved long-term disease control.
The symposium also discussed the evolving role of targeted small molecules such as Baricitinib, where clinically appropriate, in helping physicians manage selected inflammatory conditions under specialist guidance.
AA Medical Products Ltd sincerely thanks all distinguished professors, specialists, general practitioners, and healthcare professionals who participated physically and online, and contributed to making this scientific program a meaningful and successful event.
BARICIPAC — Baricitinib 4 mg Tablets - Supporting scientific discussion in chronic inflammatory disease management.
*This post is intended for medical education and professional awareness only. Patients should consult qualified healthcare professionals and specialists for diagnosis and treatment decisions.*
#AAMedicalProducts #PacificAA #BARICIPAC #Baricitinib #RethinkingInflammation #RheumatoidArthritis #AlopeciaAreata #AtopicDermatitis #MedicalEducation #MyanmarHealthcare
